T1D Program  

Diabetes Type 1 - ACT18368, DRI17476, EFC18241

Solid Tumour Studies program  

5 studies included

program 2  

Multi-study MS  

A clinical research study testing multiple MS trials

Amli Program  

Trialx QA Program  

This Program is for Testing purpose Only.

cancer2  

cancer 2 for demo.

Evaluate the Safety and Efficacy of BGT007H Cell Therapy in Patients With Relapsed/Refractory Pancreatic Cancer  

The primary objective of this study is to evaluate the safety and tolerability of BGT007H cell therapy in patients with recurrent/refractory pancreatic cancer.

The 23andMe Lung Cancer Genetic Study

people diagnosed with lung cancer and help improve care in the future. While research and targeted therapies have provided hope and progress for many, we still don't know much about the disease and its

A THREE-MONTH CLINICAL STUDY TO ASSESS PARTICIPANT EXPERIENCE, WELLNESS, PHYSIOLOGICAL AND BLOOD BIOMARKERS FOLLOWING DAILY NUTRAMETA™ ADMINISTRATION WITH A THREE-MONTH EXTENSION  

This study is evaluating an over-the-counter supplement for weight loss that uses a combination of natural ingredients that have been safely used by humans for hundreds of years. Our research suggests that a unique combination of those ingredients can have a metabolic and neurological benefit if taken over time.